Researchers and experts are always looking for a cure to end breast cancer. Cyro-Cell International, Inc. is partnering with the National Institutes of Health (NIH) to explore the potential utilization of menstrual stem cells to treat breast cancer.
Researchers seeking new and more abundant sources of stem cells for use in regenerative medicine have identified a potentially unlimited, noncontroversial, easily collectable, and inexpensive source – menstrual blood. According to an msnbc.com article “these menstrual stem cells could offer several advantages. They come from a source that's easy to obtain from women, they could be used to treat patients without the fear of tissue rejection, and they avoid ethical questions”. Furthermore, experiments in lab dishes showed that under the right conditions, the menstrual stem cells could turn into more different tissue types — including bone, blood vessel, fat, brain, lung, liver, pancreas and heart — than other adult stem cells. The new stem cells also grow readily and rapidly, which is an important advantage because it is difficult to get some types of adult stem cells to give rise to enough cells to be of any medical value.
The C'Elle Breast Cancer Donation is offering contributions to the Susan B. Komen Foundation. For every purchase of the “Protect Baby, Protect Mom” service Cyro-Cell Breast Cancer Donation will donate $50 and for each purchase of the ‘C’elle Menstrual Stem Cell” service $25 will be donated.
0 comments:
Post a Comment